Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Taher Modarressi"'
Autor:
Taher Modarressi
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100706- (2024)
Background: Lipid-related risk and residual cardiovascular risk remain high in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Significant treatment gaps exist in implementation of pluripotent and effective the
Externí odkaz:
https://doaj.org/article/25893c841e63492f9957115178d9a9d8
Autor:
Taher Modarressi, Arsalan Derakhshan
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Publikováno v:
Journal of the American College of Cardiology. 81:1870
Autor:
Taher Modarressi
Publikováno v:
Cleveland Clinic journal of medicine. 88(12)
To the Editor : The article by Mauer et al[1][1] in the August issue is an excellent and comprehensive review of antiobesity pharmacologic therapy. The authors twice mention the positive impact of antiobesity medications in reducing blood pressure. I
Autor:
Neena Passi, Fran Burke, Vivek Kulkarni, Archna Bajaj, Daniel Soffer, Meshal Soni, Patricia Hernandez, Taher Modarressi
Publikováno v:
Current Atherosclerosis Reports
Purpose of Review Hypertriglyceridemia (HTG) is common and is a significant contributor to atherosclerosis and pancreatitis risk. Specific HTG treatments have had variable success in reducing atherosclerosis risk. Novel therapies for severe HTG treat
Autor:
Taher Modarressi
Publikováno v:
Cleveland Clinic journal of medicine. 87(6)
To the Editor : The article by Shah and colleagues[1][1] is an excellent review of familial hypercholesterolemia (FH) and highlights an underdiagnosed condition on which clinicians can make a significant impact. I would like to clarify two points: Fi
Autor:
Megha Shah, Taher Modarressi
Publikováno v:
Journal of the Endocrine Society
Hodgkin lymphomas (HL) are lymphoid neoplasms formed by a conglomerate of malignant Hodgkin/Reed-Sternberg cells with heterogeneous non-neoplastic inflammatory cells. Classic HL (cHL), one of two major subtypes, comprises 90% of all cases. HL typical
Autor:
Taher Modarressi
Publikováno v:
Journal of the Endocrine Society
There is growing popularity and interest in very-low-carbohydrate (VLC) diets for a variety of established and perceived health benefits. While some impacts have been seen in cardiometabolic diseases such as diabetes, hypertension and short-term weig
Autor:
Arsalan Derakhshan, Taher Modarressi
Publikováno v:
Mayo Clinic Proceedings. 95:2568-2569
Publikováno v:
The Journal of clinical endocrinology and metabolism. 104(11)